publication venue for
- Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome? 2022
- Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies.. 20. 2020
- All in the family? Communication of cancer survivors with their families.. 16. 2017
- Modeling the dyadic effects of parenting, stress, and coping on parent-child communication in families tested for hereditary breast-ovarian cancer risk.. 15. 2016
- Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP.. 13. 2014
- Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer.. 12. 2013
- Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissue.. 5. 2006
- The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds.. 4. 2005
- Universal screening for microsatellite instability in colorectal cancer in the clinical genomics era: new recommendations, methods, and considerations.. 16. 2017
- Editorial for familial cancer: cascade genetic testing. 2024
- Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs. 2024